PrEP, Female, Oral Monitor + HIV RNA
Also known as: HIV, PrEP, Prophylaxis
Use
This profile aligns with current guidelines for monitoring female patients on oral HIV PrEP.
Special Instructions
Not provided.
Limitations
Negative results do not rule out the possibility of HIV exposure or infection. False negatives may result if the antigen or antibody quantity is too low for detection or if the disease stage at the time of sample collection does not coincide with presence of detectable markers. Reactive HIV p24 antigen/antibody results need further investigation through supplemental testing to ascertain an HIV diagnosis.
Methodology
Immunoassay (ECLIA)
Biomarkers
LOINC Codes
- 56888-1 - HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
- 25835-0 - HIV1 RNA SerPl Ql NAA+probe
- 69353-1 - HIV 2 RNA SerPl Ql NAA+probe
- 55752-0 - Clinical info
- 47236-5 - T palldm IgG+IgM SerPl Ql IA
- 43304-5 - C trach rRNA Spec Ql NAA+probe
- 43305-2 - N gonorrhoea rRNA Spec Ql NAA+probe
- 11502-2 - Laboratory report
- 45194-8 - HCG Intact+B SerPl-aCnc
Result Turnaround Time
2-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
5.5 mL
Minimum Volume
4.5 mL
Container
Gel-barrier tube
Collection Instructions
Usual blood collection technique. Centrifuge sample within 24 hours and transfer serum to a screw-cap polypropylene transport tube.
Storage Instructions
Gel-barrier tubes must be kept refrigerated for up to 7 days, frozen for up to 6 weeks.
Causes for Rejection
Hemolysis, lipemia, received outside of specimen and/or storage and/or labeling requirements, aliquot received for HIV testing, specimen in expired transport or incorrect transport device, specimens with inappropriate source for test requested.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 30 days |
| Refrigerated | 7 days |
| Frozen | 6 weeks |
Other tests from different labs that may be relevant